Trials / Conditions / Ocular Hypertension (OHT)

Ocular Hypertension (OHT)

11 registered clinical trials studyying Ocular Hypertension (OHT) — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Direct vs Standard SLT for Glaucoma: A Noninferiority Trial NCT07408154	Medical University of South Carolina	Phase 4
Recruiting	Safety and Efficacy of iDose® TR With Cataract Surgery vs. Cataract Surgery Alone NCT06848946	Glaukos Corporation	Phase 4
Completed	Qlaris Study of QLS-111 in Combination With a PGA for OAG and/or OHT Patients NCT06249152	Qlaris Bio, Inc.	Phase 2
Completed	Qlaris Phase 2 Study of QLS-111 in POAG And/or OHT Patients NCT06016972	Qlaris Bio, Inc.	Phase 2
Completed	Study of Fixed-Dose Combinations of Trabodenoson and Latanoprost in Adults With OHT or POAG NCT02829996	Inotek Pharmaceuticals Corporation	Phase 2
Completed	Study of Trabodenoson in Adults With Ocular Hypertension or Primary Open-angle Glaucoma NCT02565173	Inotek Pharmaceuticals Corporation	Phase 3
Terminated	Safety and Efficacy of Deep Wave Trabeculoplasty (DWT) in Primary Open Angle Glaucoma and Ocular Hypertension NCT02226094	OcuTherix, Inc.	Phase 1 / Phase 2
Completed	A Phase II Study to Evaluate the Additivity of Trabodenoson to Latanoprost in Adults With Ocular Hypertension NCT01917383	Inotek Pharmaceuticals Corporation	Phase 2
Completed	Single and Multiple Dose Escalation and Two-sequence Crossover Study of ONO-9054 in Patients With Ocular Hyper NCT01670266	Ono Pharma USA Inc	Phase 1
Completed	AL-54478 Proof of Concept Study NCT01318252	Alcon Research	Phase 2
Terminated	Safety Study of Latanoprost Slow Release Insert NCT01180062	Daniel Moore	Phase 1